Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Co-design of an Eye-tracking Communication Tool and a Feasibility Randomized Controlled Trial in Conscious Non-verbal ICU Patients in Shanghai, China: Protocol for a Two-phase Mixed-methods Study

NCT07205419 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT07205419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07205419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Co-design of an Eye-tracking Communication Tool and a Feasibility Randomized Controlled Trial in Conscious Non-verbal ICU Patients in Shanghai, China: Protocol for a Two-phase Mixed-methods Study
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 30, 2027
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

communication barriers, eye-tracking technology, icu patients